Evaluation of an injectable progestin-estrogen as a contraceptive.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000568:Amenorrhea / Q000139:chemically induced; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D003270:Contraceptive Agents / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D004717:Endometrium / Q000187:drug effects; D004958:Estradiol / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000008:administration & dosage* / Q000009:adverse effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D010912:Pituitary-Adrenal Function Tests
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003270:Contraceptive Agents; D003692:Delayed-Action Preparations; D004958:Estradiol; D008525:Medroxyprogesterone